Related Experiment Videos

Brain and skeletal muscle monoamine oxidase activity in schizophrenia

Schizophrenia Bulletin
|January 1, 1980
PubMed

Insights

Studies on chronic schizophrenics show no definitive evidence of reduced brain monoamine oxidase (MAO) activity, suggesting it

Area of Science:

  • Neuroscience
  • Psychiatry
  • Biochemistry

Background:

  • Monoamine oxidase (MAO) activity in postmortem brain specimens of chronic schizophrenics has been investigated.
  • Previous studies on MAO activity in schizophrenia brains yielded inconclusive results due to potential errors in postmortem analysis.

Purpose of the Study:

  • To evaluate the role of monoamine oxidase (MAO) activity in the pathogenesis of psychosis.
  • To investigate the correlation between brain and platelet MAO activities.
  • To explore the potential inhibitory effects of neuroleptic drugs on human brain MAO activity.

Main Methods:

  • Analysis of postmortem brain specimens from chronic schizophrenics and comparison groups.
  • Comparison of MAO activity in brain and platelet samples.
  • Review of indirect evidence from spinal fluid and postmortem studies regarding neuroleptic drug effects.

Main Results:

  • No consistent evidence for decreased MAO activity in the brains of schizophrenic patients was found.
  • Significant correlation between brain and platelet MAO activities in humans was absent.
  • Decreased MAO activity was observed in the skeletal muscle of psychotic patients compared to controls.

Conclusions:

  • Reduced brain MAO activity is unlikely to be significant in the pathogenesis of psychosis, as substantial inhibition is required for functional impact.
  • Peripheral MAO activity in skeletal muscle may serve as a nonspecific marker for psychopathology vulnerability.
  • Further research is needed to clarify the role of MAO in psychiatric disorders.

Related Concept Videos